A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain

A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain

Authors: Mengya Chai, Yajuan Guo, Liu Yang, Jianhui Li, Shuo Liu, Lei Chen, Yuelei Shen, Yi Yang, Youchun Wang, Lida Xu, Changyuan Yu

Citation: Zhang R, Zhang J, Zhou X, Zhao A, Yu C. The establishment and application of CD3E humanized mice in immunotherapy. Exp Anim. 2022 May 13. doi: 10.1538/expanim.22-0012. Epub ahead of print. PMID: 35570001.

Used in this study: RenMab Mice

Read entire article

Share:

Back to top